Literature DB >> 8732227

Neuroleptic malignant syndrome.

M F Bristow1, D Kohen.   

Abstract

Neuroleptic malignant syndrome is a rare, idiosyncratic condition related to neuroleptic use which may develop at any stage during neuroleptic treatment and can prove fatal. Although most commonly seen in psychiatric patients, anyone prescribed a neuroleptic is at risk and it has been associated with other agents. This article discusses its recognition, risk factors, clinical course and treatment, together with a summary of current thinking on its aetiology.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8732227

Source DB:  PubMed          Journal:  Br J Hosp Med        ISSN： 0007-1064


  3 in total

1.  [A neuroleptic malignant syndrome complicated by subarachnoid hemorrhage and revealing cerebral vasculitis].

Authors:  Toufik Jouali; Brahim Boukatta; Brahim Bechri; Nawfel Houari; Abderahim Bouazzaoui; Hicham Sbai; Nabil Kanjaa
Journal:  Pan Afr Med J       Date:  2014-11-05

2.  A retrospective analysis of cases with neuroleptic malignant syndrome and an evaluation of risk factors for mortality.

Authors:  Aynur Sahin; Mustafa Cicek; Ozgen Gonenc Cekic; Mucahit Gunaydin; Demet Saglam Aykut; Ozgur Tatli; Yunus Karaca; Mualla Aylin Arici
Journal:  Turk J Emerg Med       Date:  2017-11-27

3.  Malignant Catatonia and Neuroleptic Malignant Syndrome in Relation to Disulfiram Overdose.

Authors:  Kiran K Kumar; Swapna Bondade; Fiaz Ahmed Sattar; Niharika Singh
Journal:  Indian J Psychol Med       Date:  2016 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.